CIK: 1721442 - Address: C/O Teva Pharmaceutical Industries Ltd., 124 Dvora Hanevi'A St.,, Tel Aviv, L3 6944020
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

3/7/24 16:12
3/5/24
TEVATeva Pharmaceutical Industries LtdL3HealthDrugPharmaceutical PreparationsSabag MarkL3OEVP,InteM.d00.0008227383D
3/7/24 16:12
3/5/24
TEVATeva Pharmaceutical Industries LtdL3HealthDrugPharmaceutical PreparationsSabag MarkL3OEVP,InteS.d-1,35213.520-100-21383D
3/5/24 16:12
3/3/24
TEVATeva Pharmaceutical Industries LtdL3HealthDrugPharmaceutical PreparationsSabag MarkL3OEVP,InteM.dm00.0005817401D
3/1/24 06:52
2/28/24
TEVATeva Pharmaceutical Industries LtdL3HealthDrugPharmaceutical PreparationsSabag MarkL3OEVP,InteM.d00.000216342D
3/7/23 16:11
3/4/23
TEVATeva Pharmaceutical Industries LtdL3HealthDrugPharmaceutical PreparationsSabag MarkL3OEVP,InteM.dm00.0007329322D
3/2/23 07:36
2/28/23
TEVATeva Pharmaceutical Industries LtdL3HealthDrugPharmaceutical PreparationsSabag MarkL3OEVP,InteM.d00.0007140248D
3/8/22 16:11
3/4/22
TEVATeva Pharmaceutical Industries LtdL3HealthDrugPharmaceutical PreparationsSabag MarkL3OEVP,InteM.dm00.0008388178D
3/2/22 07:50
2/28/22
TEVATeva Pharmaceutical Industries LtdL3HealthDrugPharmaceutical PreparationsSabag MarkL3OEVP,InteM.d00.000212895D
2/10/22 16:10
2/9/22
TEVATeva Pharmaceutical Industries LtdL3HealthDrugPharmaceutical PreparationsSabag MarkL3OEVP,InteM.d00.000162774D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact